Director, Field Medical (Remote) at Freenome

Brisbane, California, United States

Apply Now

Not SpecifiedCompensation

Senior (5 to 8 years), Expert & Leadership (9+ years)Experience Level

Full TimeJob Type

UnknownVisa

Biotechnology, Healthcare, OncologyIndustries

Requirements

Proven track record identifying KOLs and payors nationally
Experience addressing clinical knowledge gaps across a wide range of customers by communicating impactful scientific information
Passion for patient care
Ability to engage clinicians (primary care physicians, oncologists, gastroenterologists, pathologists, APPs) and managed care/payor customers
Capability to drive field medical strategy across all products

Responsibilities

Identify and develop relationships with key decision makers in academic and community clinics, hospital systems, payor/managed care organizations, and other institutions that influence or manage the use of screening products
Collaborate with clinical and payor customers to understand their needs, knowledge gaps, challenges, and evidence requirements for clinical integration, reimbursement, and coverage
Develop timely and strategic territory/account plans to address customer needs
Educate and conduct meaningful scientific exchange with clinicians on the clinical attributes of Freenome products
Educate managed care/payors on the clinical value of Freenome products and services to drive plan inclusion and appropriate utilization
Provide support for on-site oral presentations, data reviews, and interactive education events for Key Opinion Leaders (KOLs)
Stay abreast of the latest scientific and clinical advancements, market trends, and regulatory guidelines relevant to products, specifically in relation to market access, clinical, IDN, and payor environments
Represent the company at industry conferences, meetings, and other events as a thought leader and foster key relationships
Assist in organizing forums and events for KOLs to discuss clinical challenges, unmet needs, and potential product improvements
Identify trends impacting patient access to blood-based cancer screening
Provide updates and briefings to key internal stakeholders
Partner closely with internal teams including Commercial and Medical Affairs

Skills

Field Medical Affairs

Medical Strategy

KOL Engagement

Clinician Interaction

Payor Engagement

Primary Care Physicians

Oncologists

Gastroenterologists

Pathologists

Managed Care

Freenome

Biotechnology company for early cancer detection

About Freenome

Freenome focuses on improving cancer detection through advanced blood tests. The company uses a multiomics approach, analyzing various biological data types, including genomics and proteomics, to find cancer markers in blood samples. This method allows for non-invasive early detection of cancer, which is crucial for effective treatment. Freenome differentiates itself from competitors by its unique combination of data analysis techniques and its commitment to clinical trials and research collaborations. The company's goal is to enhance cancer diagnostics and make early detection accessible to healthcare providers and patients, ultimately aiming to save lives through timely intervention.

San Francisco, CaliforniaHeadquarters

2014Year Founded

$1,032.6MTotal Funding

LATE_VCCompany Stage

Biotechnology, HealthcareIndustries

201-500Employees

Benefits

Competitive market-based salaries

Annual bonus opportunities

Relocation packages

Medical, dental, & vision coverage

401k

Wellness programs

Equity

PTO

Risks

Employee layoffs may affect morale and innovation efforts.

Integration of Oncimmune Ltd. could divert focus from core projects.

Competitive landscape in cancer detection may impact Freenome's market share.

Differentiation

Freenome uses a unique multiomics approach for early cancer detection.

The company focuses on non-invasive blood tests for cancer screening.

Freenome's platform designs personalized health conditions based on cell-free genome analysis.

Upsides

Recent $254 million funding boosts clinical programs and platform expansion.

Partnership with Walgreens enhances clinical trial diversity and patient recruitment.

PROACT LUNG study positions Freenome as a leader in lung cancer diagnostics.

Land your dream remote job 3x faster with AI

Try Jobo Free